Long-Acting Growth Hormones to Account for More than 90% of Market Share across US, Germany, and Japan by 2030: Report

November 22, 2021

Rapid uptake of long-acting growth hormones (GH) is set to shake up the growth hormone deficiency (GHD) space in the three major markets (3MM): the US, Germany, and Japan. These therapies are projected to capture more than 90% of market share in this region by 2030 due to their potential to improve patient convenience and […]

To view the full Member Resource, please Log in

TOPICS IN THIS ARTICLE:

←Endocrine Society Celebrates House Passage of Build Back Better Act

COVID-19 May Trigger Hyperglycemia and Worsen Disease by Harming Fat Cells→

View Archives

Join the Global Movement Advancing Endocrine Science and Medicine

Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.

Join Today